Linnaeus Therapeutics closed a $4.48 million equity round and won up to $22 million from a federal health agency. The company is studying pathways that may influence aging and disease.

Abstract: Designing safety-critical controllers for acceleration-controlled unicycle robots is challenging, as control inputs may not appear in the constraints of control Lyapunov functions (CLFs) and ...